- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Feminine Health Care Prd
Columbia Laboratories Inc
+ Add to WatchlistCBRX:US
0.6478 USD 0.0015 0.23%As of 20:10:00 ET on 05/17/2013.
Snapshot for Columbia Laboratories Inc (CBRX)
| Open: | 0.6320 | Day's Range: | 0.6301 - 0.6500 | Volume: | 260,538 |
|---|---|---|---|---|---|
| Previous Close: | 0.6463 | 52wk Range: | 0.5510 - 1.2300 | 1-Yr Rtn: | -2.29% |
Key Statistics for CBRX
| Current P/E Ratio (ttm) | 12.9560 |
|---|---|
| Estimated P/E(12/2013) | 9.2543 |
| Relative P/E vs. SPX | 0.7941 |
| Earnings Per Share (USD) (ttm) | 0.0500 |
| Est. EPS (USD) (12/2013) | 0.0700 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 56.78 |
| Shares Outstanding (M) | 87.65 |
| 30 Day Average Volume | 340,058 |
| Price/Book (mrq) | 1.8644 |
| Price/Sale (ttm) | 1.9981 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBRX
Company Profile & Key Executives for CBRX
Columbia Laboratories, Inc. is an international pharmaceutical company that develops and markets women's health care and endocrinology products. The Company develops products intended to treat infertility, dysmenorrhea, endometriosis, and hormonal deficiencies, primarily utilizing its Bioadhesive Delivery System technology. Columbia markets Striant, and Prochieve 8% and 4%.
| Frank C Condella JrPresident/CEO | Jonathan B Lloyd JonesVP:Finance/CFO/Treasurer/Secy |
| Amy RaskopfManager:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CBRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page